Pediatric Non-alcoholic Fatty Liver Disease

Area of Science:

• Pediatric gastroenterology and hepatology
• Public health and epidemiology
• Microbiome research

Background:

• Childhood obesity affects over one-third of American children, increasing liver disease prevalence.
• Non-alcoholic fatty liver disease (NAFLD) is now the most common chronic liver disease in children.
• Emerging research investigates the complex factors contributing to pediatric NAFLD.

Purpose of the Study:

• To review current understanding of pediatric NAFLD, including pathogenesis and genetic factors.
• To highlight advancements in non-invasive diagnostic methods for hepatic steatosis and fibrosis.
• To summarize treatment strategies, focusing on lifestyle interventions and ongoing clinical trials.

Main Methods:

• Literature review of pathogenesis, genetics, and microbiome in pediatric NAFLD.
• Analysis of new non-invasive diagnostic modalities for liver conditions.
• Overview of current lifestyle and pharmacological treatment trials.

Main Results:

• Significant increase in pediatric NAFLD cases linked to obesity epidemic.
• Development of novel non-invasive techniques for diagnosing liver conditions in children.
• Ongoing clinical trials exploring innovative treatments for pediatric NAFLD.

Conclusions:

• Pediatric NAFLD is a growing public health concern requiring further research.
• Non-invasive diagnostics are crucial for monitoring disease progression in children.
• Lifestyle interventions combined with emerging therapies offer hope for managing pediatric NAFLD.